Volume 7, Supplement 1 (Mar 2016)

The Advanced Practitioner's Guide to Multiple Myeloma

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

A continuing education activity for nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

This CME/CE/CEU accredited supplement is jointly provided by

This supplement has been developed by members of the International Myeloma Foundation Nurse Leadership Board

Faculty

Page Bertolotti, RN, BSN, OCN, Samuel Oschin Cancer Center at Cedars-Sinai Medical Center

Kevin Brigle, PhD, NP, VCUHS Massey Cancer Center

Donna D. Catamero, ANP-BC, OCN, CCRC, Mount Sinai Medical Center

Kathleen Colson, RN, BSN, BS, Dana-Farber Cancer Center

Hollie Devine, MSN, ANP-BC, The Ohio State University Medical Center James Cancer Hospital

Deborah Doss, RN, OCN, Dana-Farber Cancer Center

Beth Faiman, PhD, MSN, APRN-BC, AOCN, Cleveland Clinic Taussig Cancer Institute

Elizabeth Finley-Oliver, RN, BSN, OCN, H. Lee Moffitt Cancer Center and Research Institute

Charise Gleason, MSN, NP-BC, AOCNP, Winship Cancer Institute of Emory University

Sandra Kurtin, RN, MSN, AOCN, ANP-C, The University of Arizona Cancer Center

Patricia A. Mangan, RN, MSN, APRN-BC, Abramson Cancer Center at the University of Pennsylvania

Ali McBride, PharmD, MS, BCPS, BCOP, The University of Arizona Cancer Center

Ann McNeill, RN, MSN, APN, John Theurer Cancer Center at HUMC

Teresa Miceli, RN, BSN, OCN, Mayo Clinic-Rochester

Kimberly Noonan, RN, ANP, AOCN, Dana-Farber Cancer Center

Tiffany Richards, MS, ANP, AOCNP, MD Anderson Cancer Center

Sandra Rome, RN, MN, AOCN, CNS, Cedars-Sinai Medical Center

Joseph Tariman, PhD, ANP-BC, DePaul University

Daniel Verina, BS, BSN, MSN, ACNP-BC, Mount Sinai Medical Center

This supplement is provided by independent educational grants from the following companies: Takeda Oncology, Celgene Corporation, Binding Site, and Adaptive Biotechnologies.